Pink Sheet is part of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

UK prescribing rights

This article was originally published in The Tan Sheet

Executive Summary

Pharmacists and nurses in the UK have been granted the ability to prescribe any licensed medication for any medical condition, except for controlled drugs, beginning in Spring 2006, British Health Secretary Patricia Hewitt announces Nov. 10. Nurses and pharmacists would be required to undergo training and registration to gain prescribing privileges, the Department of Health states. "By expanding traditional prescribing roles, patients can more easily access the medicines they need from an increased number of highly trained health professionals," Hewitt states. The Medicines & Healthcare products Regulatory Agency requested comments on extended prescribing rights in March (1"The Tan Sheet" March 14, 2005, p. 17)...

You may also be interested in...



UK prescribing

The British Medical Association has called for an "urgent meeting" with British Health Secretary Patricia Hewitt following the UK's announcement to grant prescribing powers to nurses and pharmacists. Hewitt said Nov. 10 that nurses and pharmacists will be afforded prescribing rights for any medical condition, excluding controlled drugs, beginning in Spring 2006 if they complete additional training (1"The Tan Sheet" Nov. 21, 2005, In Brief). "It is difficult to see how healthcare professionals who are not trained to diagnose disease can safely prescribe appropriate treatment," BMA Chairman James Johnson states in a release. Central Consultants & Specialists Committee Chairman Paul Miller called the decision an "irresponsible and dangerous move. Patients will suffer. I would not have me or my family subject to anything other than the highest level of care and prescribing, which is that provided by a fully trained doctor"...

Bayer Confident CureVac COVID Pact Will Be A Success

CEO Werner Baumann admits he was skeptical at first as to whether the German group had the necessary know-how to manufacture vaccines but the firm's expertise in the development of biotech products has strengthened his belief Bayer can deliver.

EMA Works On Defining Metadata From RWD Sources

As part of its big data initiative, the European Medicines Agency is supporting projects that will help identify appropriate real-world data sources for regulatory decision making.

Topics

UsernamePublicRestriction

Register

OM017301

Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel